We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On November 12, 2009, Justice Hughes of the Federal Court allowed two judicial review applications of Teva Neuroscience G.P.-S.E.N.C. in respect of two decisions made by the Patented Medicine Prices Review Board
The Patented Medicine Prices Review Board ("PMPRB") recently released its decision in the matter of Hoechst Marion Roussel Canada Inc. and the medicine NIOCODERM, a nicotine patch which assists those who are attempting to quit smoking; it is to be publicly posted on the PMPRB website today
